Education
Hemophilia
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly because of low levels of a clotting factor — factor VIII in hemophilia A, or factor IX in hemophilia B. The resources below offer research and guidance on treatment and care.
Hemophilia Resources
- Role of New Prolonged Half-Life Clotting Factors in Hemophilia(opens in a new tab)
- Value of Prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.(opens in a new tab)
- Non-factor replacement therapy for haemophilia: a current update(opens in a new tab)
- Hemophilia trials in the twenty-first century: Defining patient important outcomes.(opens in a new tab)
- Using pharmacokinetic for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.(opens in a new tab)
- Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B.(opens in a new tab)
- Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.(opens in a new tab)
- Emicizumab Prophylaxis in Hemophilia A patients with Inhibitors(opens in a new tab)
- Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999-2010: a surveillance project.(opens in a new tab)
- Effects of a 6-week, Individualized, Supervised Exercise Program for People with Bleeding Disorders and Hemophilic Arthritis.(opens in a new tab)
- Inhibitors of propagation of coagulation (factors VIII, IX, and XI): a review of current therapeutic practice(opens in a new tab)
- Acquired Factor VIII Inhibitors: Pathophysiology and Treatment(opens in a new tab)
- Optimal management of hemophilic arthropathy and hematomas(opens in a new tab)